Hou‐Qun Ying

2.6k total citations
62 papers, 2.0k citations indexed

About

Hou‐Qun Ying is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Hou‐Qun Ying has authored 62 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 22 papers in Cancer Research and 17 papers in Molecular Biology. Recurrent topics in Hou‐Qun Ying's work include Inflammatory Biomarkers in Disease Prognosis (23 papers), Cancer, Lipids, and Metabolism (12 papers) and Gastric Cancer Management and Outcomes (9 papers). Hou‐Qun Ying is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (23 papers), Cancer, Lipids, and Metabolism (12 papers) and Gastric Cancer Management and Outcomes (9 papers). Hou‐Qun Ying collaborates with scholars based in China, United States and Bangladesh. Hou‐Qun Ying's co-authors include Yuqin Pan, Huiling Sun, Qiwen Deng, Shukui Wang, Xian Liu, Bangshun He, Bangshun He, Jie Chen, Feng Wang and Shukui Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Hou‐Qun Ying

60 papers receiving 2.0k citations

Peers

Hou‐Qun Ying
Hou‐Qun Ying
Citations per year, relative to Hou‐Qun Ying Hou‐Qun Ying (= 1×) peers Shirong Cai

Countries citing papers authored by Hou‐Qun Ying

Since Specialization
Citations

This map shows the geographic impact of Hou‐Qun Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hou‐Qun Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hou‐Qun Ying more than expected).

Fields of papers citing papers by Hou‐Qun Ying

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hou‐Qun Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hou‐Qun Ying. The network helps show where Hou‐Qun Ying may publish in the future.

Co-authorship network of co-authors of Hou‐Qun Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Hou‐Qun Ying. A scholar is included among the top collaborators of Hou‐Qun Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hou‐Qun Ying. Hou‐Qun Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ying, Hou‐Qun, Ang Gao, Daping Qiu, et al.. (2025). Bimetallic Substitution Engineering Enabled Fast‐Charging Layered Oxide Cathodes for Potassium‐Ion Batteries. Advanced Functional Materials. 36(14).
2.
Zong, Zhen, et al.. (2022). Application of Machine Learning Algorithms to Predict Lymph Node Metastasis in Early Gastric Cancer. Frontiers in Medicine. 8. 759013–759013. 21 indexed citations
3.
Ying, Hou‐Qun, et al.. (2021). Role of Chronic Inflammatory Ratios in Predicting Recurrence of Resected Patients with Stage I–III Mucinous Colorectal Adenocarcinoma. Cancer Management and Research. Volume 13. 3455–3464. 7 indexed citations
4.
Ying, Hou‐Qun, et al.. (2021). High-Grade Inflammation Attenuates Chemosensitivity and Confers to Poor Survival of Surgical Stage III CRC Patients. Frontiers in Oncology. 11. 580455–580455. 4 indexed citations
5.
Wang, Xiaozhong, et al.. (2020). <p>A Novel Prognostic Score Based on <em>ZG16</em> for Predicting CRC Survival</p>. Pharmacogenomics and Personalized Medicine. Volume 13. 735–747. 2 indexed citations
6.
Sun, Fan, Yao Li, Wei Wang, et al.. (2019). Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients. Frontiers in Oncology. 9. 723–723. 13 indexed citations
7.
Gao, Qiu‐Fang, Xiaohong Huang, Yanmei Xu, et al.. (2018). The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy. Cancer Cell International. 18(1). 153–153. 31 indexed citations
8.
Yang, Weiming, Hou‐Qun Ying, Yanmei Xu, et al.. (2018). Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: Albumin to fibrinogen ratio and C-reactive protein to albumin ratio. International Immunopharmacology. 62. 293–298. 72 indexed citations
9.
Wang, Shukui, et al.. (2016). Different effects of the three polymorphisms on 15q25.1 onlung cancer risk: Evidence from published literatures. Journal of Cancer Research and Therapeutics. 12(1). 12–12. 5 indexed citations
10.
Deng, Qiwen, Bangshun He, Xian Liu, et al.. (2015). Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. Journal of Translational Medicine. 13(1). 66–66. 167 indexed citations
11.
Chen, Jie, Yuqin Pan, Bangshun He, et al.. (2015). Inhibition of CD147 expression by RNA interference reduces proliferation, invasion and increases chemosensitivity in cancer stem cell-like HT-29 cells. International Journal of Oncology. 47(4). 1476–1484. 10 indexed citations
12.
Ying, Hou‐Qun, Jie Chen, Bangshun He, et al.. (2015). The effect of BIM deletion polymorphism on intrinsic resistance and clinical outcome of cancer patient with kinase inhibitor therapy. Scientific Reports. 5(1). 11348–11348. 20 indexed citations
13.
Pan, Yuqin, Bangshun He, Jie Chen, et al.. (2015). Gene therapy for colorectal cancer by adenovirus-mediated siRNA targeting CD147 based on loss of the IGF2 imprinting system. International Journal of Oncology. 47(5). 1881–1889. 10 indexed citations
14.
Yu, Bo, et al.. (2015). Association between the CYP1A1 polymorphisms and hepatocellular carcinoma: a meta-analysis. Genetics and Molecular Research. 14(1). 1076–1084. 5 indexed citations
15.
Deng, Qiwen, Bangshun He, Tianyi Gao, et al.. (2014). Up-Regulation of 91H Promotes Tumor Metastasis and Predicts Poor Prognosis for Patients with Colorectal Cancer. PLoS ONE. 9(7). e103022–e103022. 75 indexed citations
16.
Deng, Qiwen, Huiling Sun, Bangshun He, et al.. (2014). Prognostic Value of Long Non-Coding RNA HOTAIR in Various Cancers. PLoS ONE. 9(10). e110059–e110059. 32 indexed citations
17.
Ying, Hou‐Qun, Yue Qi, Xiaoying Pu, Shuoran Liu, & A Zhou-Cun. (2013). Association of GSTM1 and GSTT1 Genes with the Susceptibility to Male Infertility: Result from a Meta-Analysis. Genetic Testing and Molecular Biomarkers. 17(7). 535–542. 8 indexed citations
18.
Ying, Hou‐Qun, Xiaoying Pu, Shuoran Liu, & A Zhou-Cun. (2013). Genetic variants of eNOS gene may modify the susceptibility to idiopathic male infertility. Biomarkers. 18(5). 412–417. 13 indexed citations
20.
Ying, Hou‐Qun, Matthew B. Scott, & A Zhou-Cun. (2012). Relationship of SNP of H2BFWT gene to male infertility in a Chinese population with idiopathic spermatogenesis impairment. Biomarkers. 17(5). 402–406. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026